UI Researchers Find Possible Genetic Link Between The X Chromosome And Ovarian Cancer

March 01, 1999

IOWA CITY, Iowa -- An imbalance in how genes are expressed on a female's two X chromosomes may lead to the development of ovarian cancer in some women, University of Iowa Cancer Center researchers report in a study published in the Feb. 17 issue of the Journal of the National Cancer Institute.

The study's principal investigator, Richard E. Buller, M.D., Ph.D., UI professor of obstetrics and gynecology, and pharmacology, said the research suggests that a gene on the X chromosome that is involved with invasive ovarian cancer may also influence the effects of BRCA1, a separate gene known to cause hereditary breast and ovarian cancer.

The study examined 213 women with invasive ovarian cancer, 44 women with borderline ovarian cancer and 50 women without any personal or family history of cancer. Eleven of the women who inherited BRCA1 gene mutations were among those with invasive ovarian cancer. Of those 11 women, nine had nonrandom X-chromosome inactivation, a genetic condition in which one set of chromosomes, either maternal or paternal, is more active in all cells of the body.

"This suggests that there may be a factor on the X chromosome that interacts with the BRCA1 gene product or influences its expression. This phenomenon could explain why women in the same family carrying the same BRCA1 mutation develop cancer at significantly different ages," Buller said.

Buller explained that the cells of female embryos each contain two X chromosomes, one from each parent. In the early stages of development, one of the X chromosomes is "turned off" in each cell to avoid biological problems that would otherwise develop if both chromosomes remained active. Usually, the process of one chromosome becoming inactive is random and, as a result, a female ends up genetically as a "mosaic" with nearly the same number of cells containing an active paternal X chromosome as cells containing an active maternal X chromosome.

But as the study showed, this genetic balance is usually not the case for women with ovarian cancer and especially not for those who developed ovarian cancer due to inheritance of a mutant BRCA1 gene.

"The uneven distribution violates a basic biological principle," Buller explained.

Buller said his team found that in women with invasive ovarian cancer, more than 50 percent had either a paternal or maternal chromosome active in most, rather than in just half, of their cells. When a mutant BRCA1 gene was also present, 90 percent of the women had this nonrandom X-chromosome inactivation. By comparison, the team found such chromosomal imbalance in only 28 percent of the women with borderline ovarian cancer and 33 percent of healthy women.

The next step for the UI researchers is to determine the exact location of the gene on the X chromosome that may be interacting the BRCA1, Buller said.

"The research will help us learn more about risk factors for ovarian cancer and could lead to new prevention strategies that might reduce a women's chance of getting breast or ovarian cancer," he said.

University of Iowa

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.